|
1.
|
Louis DN: Molecular pathology of malignant
gliomas. Annu Rev Pathol. 1:97–117. 2006. View Article : Google Scholar
|
|
2.
|
Rasper M, Schafer A, Piontek G, et al:
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain
tumor stem cell capacity. Neuro Oncol. 12:1024–1033. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29:15–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Verhoeff JJ, van Tellingen O, Claes A, et
al: Concerns about anti-angiogenic treatment in patients with
glioblastoma multiforme. BMC Cancer. 9:4442009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Keck PJ, Hauser SD, Krivi G, et al:
Vascular permeability factor, an endothelial cell mitogen related
to PDGF. Science. 246:1309–1312. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Leung DW, Cachianes G, Kuang WJ, Goeddel
DV and Ferrara N: Vascular endothelial growth factor is a secreted
angiogenic mitogen. Science. 246:1306–1309. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Takano S, Yoshii Y, Kondo S, et al:
Concentration of vascular endothelial growth factor in the serum
and tumor tissue of brain tumor patients. Cancer Res. 56:2185–2190.
1996.PubMed/NCBI
|
|
8.
|
Nishikawa R, Cheng SY, Nagashima R, Huang
HJ, Cavenee WK and Matsutani M: Expression of vascular endothelial
growth factor in human brain tumors. Acta Neuropathol. 96:453–462.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Berkman RA, Merrill MJ, Reinhold WC, et
al: Expression of the vascular permeability factor/vascular
endothelial growth factor gene in central nervous system neoplasms.
J Clin Invest. 91:153–159. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hamerlik P, Lathia JD, Rasmussen R, et al:
Autocrine VEGFVEGFR2-Neuropilin-1 signaling promotes glioma
stem-like cell viability and tumor growth. J Exp Med. 209:507–520.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
He H, Niu CS and Li MW: Correlation
between glioblastoma stem-like cells and tumor vascularization.
Oncol Rep. 27:45–50. 2012.PubMed/NCBI
|
|
12.
|
Gu Q, Wang D, Wang X, et al: Basic
fibroblast growth factor inhibits radiation-induced apoptosis of
HUVECs. I. The PI3K/AKT pathway and induction of phosphorylation of
BAD. Radiat Res. 161:692–702. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gingis-Velitski S, Zetser A, Flugelman MY,
Vlodavsky I and Ilan N: Heparanase induces endothelial cell
migration via protein kinase B/Akt activation. J Biol Chem.
279:23536–23541. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gerber HP, McMurtrey A, Kowalski J, et al:
Vascular endothelial growth factor regulates endothelial cell
survival through the phosphatidylinositol 3′-kinase/Akt signal
transduction pathway. Requirement for Flk-1/KDR activation. J Biol
Chem. 273:30336–30343. 1998.
|
|
15.
|
de Vries C, Escobedo JA, Ueno H, Houck K,
Ferrara N and Williams LT: The fms-like tyrosine kinase, a receptor
for vascular endothelial growth factor. Science. 255:989–991.
1992.
|
|
16.
|
Millauer B, Wizigmann-Voos S, Schnurch H,
et al: High affinity VEGF binding and developmental expression
suggest Flk-1 as a major regulator of vasculogenesis and
angiogenesis. Cell. 72:835–846. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Terman BI, Dougher-Vermazen M, Carrion ME,
et al: Identification of the KDR tyrosine kinase as a receptor for
vascular endothelial cell growth factor. Biochem Biophys Res
Commun. 187:1579–1586. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Plate KH, Breier G, Weich HA, Mennel HD
and Risau W: Vascular endothelial growth factor and glioma
angiogenesis: coordinate induction of VEGF receptors, distribution
of VEGF protein and possible in vivo regulatory mechanisms. Int J
Cancer. 59:520–529. 1994. View Article : Google Scholar
|
|
19.
|
Norden AD, Drappatz J and Wen PY:
Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol.
5:610–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Iwamoto FM and Fine HA: Bevacizumab for
malignant gliomas. Arch Neurol. 67:285–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gorski DH, Beckett MA, Jaskowiak NT, et
al: Blockage of the vascular endothelial growth factor stress
response increases the antitumor effects of ionizing radiation.
Cancer Res. 59:3374–3378. 1999.
|
|
22.
|
Graeven U, Fiedler W, Karpinski S, et al:
Melanoma-associated expression of vascular endothelial growth
factor and its receptors FLT-1 and KDR. J Cancer Res Clin Oncol.
125:621–629. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Knizetova P, Ehrmann J, Hlobilkova A, et
al: Autocrine regulation of glioblastoma cell cycle progression,
viability and radioresistance through the VEGF-VEGFR2 (KDR)
interplay. Cell Cycle. 7:2553–2561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hlobilkova A, Ehrmann J, Knizetova P,
Krejci V, Kalita O and Kolar Z: Analysis of VEGF, Flt-1, Flk-1,
nestin and MMP-9 in relation to astrocytoma pathogenesis and
progression. Neoplasma. 56:284–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Kabos P, Ehtesham M, Kabosova A, Black KL
and Yu JS: Generation of neural progenitor cells from whole adult
bone marrow. Exp Neurol. 178:288–293. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ignatova TN, Kukekov VG, Laywell ED,
Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors
contain neural stem-like cells expressing astroglial and neuronal
markers in vitro. Glia. 39:193–206. 2002. View Article : Google Scholar
|
|
27.
|
Hemmati HD, Nakano I, Lazareff JA, et al:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
29.
|
Galli R, Binda E, Orfanelli U, et al:
Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Yuan X, Curtin J, Xiong Y, et al:
Isolation of cancer stem cells from adult glioblastoma multiforme.
Oncogene. 23:9392–9400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Beier D, Hau P, Proescholdt M, et al:
CD133(+) and CD133(−) glioblastoma-derived cancer stem cells show
differential growth characteristics and molecular profiles. Cancer
Res. 67:4010–4015. 2007.
|
|
33.
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
35.
|
Bao S, Wu Q, Sathornsumetee S, et al: Stem
cell-like glioma cells promote tumor angiogenesis through vascular
endothelial growth factor. Cancer Res. 66:7843–7848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Kang SK, Park JB and Cha SH: Multipotent,
dedifferentiated cancer stem-like cells from brain gliomas. Stem
Cells Dev. 15:423–435. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2− cancer cells are similarly tumorigenic.
Cancer Res. 65:6207–6219. 2005.
|
|
38.
|
Yu SC, Ping YF, Yi L, et al: Isolation and
characterization of cancer stem cells from a human glioblastoma
cell line U87. Cancer Lett. 265:124–134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Shen G, Shen F, Shi Z, et al:
Identification of cancer stem-like cells in the C6 glioma cell line
and the limitation of current identification methods. In Vitro Cell
Dev Biol Anim. 44:280–289. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Zhou XD, Wang XY, Qu FJ, et al: Detection
of cancer stem cells from the C6 glioma cell line. J Int Med Res.
37:503–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Jain RK: Normalizing tumor vasculature
with anti-angiogenic therapy: a new paradigm for combination
therapy. Nat Med. 7:987–989. 2001. View Article : Google Scholar : PubMed/NCBI
|
